Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accelerated, accrual, Analpram, analyze, announce, announced, annum, APB, apparently, Appendix, approach, asingle, Associationpublished, broader, buying, California, capture, CEO, cessation, charter, Chemistry, CIBC, clarified, CMC, COMMISSIONWashington, committed, concluded, conjugated, contrast, Cord, corrective, corticosteroid, CRADA, critical, decline, diameter, disadvantage, disclosed, downsize, electronically, embezzled, ensure, environment, EPS, equine, Equiserve, ESTRASROB, fact, Ferndale, filer, flexibility, forensic, forward, fraud, fulfilling, furnished, Grove, guarantor, guaranty, HC, Heuer, holder, HRT, indirect, infusion, invoicing, journalStrokeprovided, Junior, law, light, Marvin, Member, methyltestosterone, micron, mind, misleading, mixed, molecularly, monthly, nanoemulsion, NE, oncombination, Pacific, PIDC, pledge, pledged, predominately, Preliminary, pressure, previsoulsy, productintended, PROESTRASORB, progesterone, PROGESTSORB, prospective, purely, reassessed, rebate, recourse, reevaluated, reevaluation, repackaging, resell, resolving, resubmission, resubmit, resubmitted, role, satisfactory, sensitivity, Settlement, Shareholder, situation, SJ, someday, standstill, subordinated, suite, synthetic, Task, TESTESTRASORB, theJournal, timeline, tolerization, tolerogen, Trust, underestimated, undertaken, unexpected, untrue, variable, voluntarily, waived, waiver, website, withdraw, withdrawal, Wyeth, yearly
Removed:
Additionally, advisory, antidilutive, antigen, bacteria, biological, cancer, consulting, discretionary, excluding, fully, hiring, Home, intact, intended, leased, lotion, maintained, miscible, privately, prototype, serve, sheet, shipped, show, smaller, spending, sponsorship, standard, stomach, superior, vested
Filing tables
Filing exhibits
NVAX similar filings
Filing view
External links
Exhibit 99.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Novavax, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Dennis W. Genge, Vice-President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 906 of the Sarbanes-Oxley Act of 2002, that:
3) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Act of 1934; and | |
4) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. | |
By: /s/ Dennis W. Genge | ||
Name: | Dennis W. Genge | ||
Title: | Vice-President and Chief Financial Officer |
March 27, 2003 |